EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

Robert W Cross iD, Megan L Heinrich, Karla A Fenton iD, Viktoriya Borisevich, Krystle N Agans iD, Abhishek N Prasad iD, Courtney Woolsey iD, Daniel J Deer, Natalie S Dobias iD, Megan M Rowland, Raju Lathigra, Rodrigo Borrega iD und 4 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2304876120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Robert W Cross und 15 weiteren Autor:innen. Beteiligte Einrichtung: Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555. Hauptthemen laut MEDLINE: Lassa virus, Lassa Fever. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are no approved treatments for Lassa fever (LF), which is responsible for thousands of deaths each year in West Africa. A major challenge in developing effective medical countermeasures against LF is the high diversity of circulating Lassa virus (LASV) strains with four recognized lineages and four proposed lineages. The recent resurgence of LASV in Nigeria caused by genetically distinct strains underscores this concern. Two LASV lineages (II and III) are dominant in Nigeria. Here, we show that combinations of two or three pan-lineage neutralizing human monoclonal antibodies (8.9F, 12.1F, 37.D) known as Arevirumab-2 or Arevirumab-3 can protect up to 100% of cynomolgus macaques against challenge with both lineage II and III LASV isolates when treatment is initiated at advanced stages of disease on day 8 after LASV exposure. This work demonstrates that it may be possible to develop postexposure interventions that can broadly protect against most strains of LASV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa virusLassa FeverAnimalsHumansAfrica, WesternAntibodies, MonoclonalAntibodies, NeutralizingMacaca fascicularis

Stichwörter der Autor:innen

antibodyarenaviruslassa virusprimatetreatment

Substanzen

Antibodies, MonoclonalAntibodies, Neutralizing

Autor:innen und Institutionen

  • Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
  • Zalgen Labs, Limited Liability Company, Frederick, MD 21703.
  • Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112.

ORCID-Profile: Robert W Cross, Karla A Fenton, Krystle N Agans, Abhishek N Prasad, Courtney Woolsey, Natalie S Dobias, Rodrigo Borrega, Robert F Garry, Thomas W Geisbert

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Cross, R. W., Heinrich, M. L., Fenton, K. A., Borisevich, V., Agans, K. N., Prasad, A. N., Woolsey, C., Deer, D. J., Dobias, N. S., Rowland, M. M., Lathigra, R., Borrega, R., Geisbert, J. B., Garry, R. F., Branco, L. M., & Geisbert, T. W. (2023). A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2304876120

Vancouver

Cross RW, Heinrich ML, Fenton KA, Borisevich V, Agans KN, Prasad AN, et al. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2304876120

BibTeX
@article{Cross2023,
  author = {Cross, Robert W and Heinrich, Megan L and Fenton, Karla A and Borisevich, Viktoriya and Agans, Krystle N and Prasad, Abhishek N and Woolsey, Courtney and Deer, Daniel J and Dobias, Natalie S and Rowland, Megan M and Lathigra, Raju and Borrega, Rodrigo and Geisbert, Joan B and Garry, Robert F and Branco, Luis M and Geisbert, Thomas W},
  title = {A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2304876120}
}
Kostenlos starten →